intron-22 (I22) contains two nested genes, F8 A and F8 B , which are depicted in red and blue, respectively (also see Fig. 1a ). Also present in I22 is an ~10 kb sequence referred to as int22h1 (purple), almost identical in sequence to two extra-genic segments upstream of F8, referred to as int22h2 and int22h3; F8 A as well as exon-1 of F8 B are situated entirely within int22h1. Note that the exons and introns are not drawn to scale. (b) Schematic representation of the intrachromosomal chiasmata that give rise to an I22-inverted F8 locus. The upper panel depicts a region of Xq28 that includes the wild-type F8 locus oriented with the telomere (tel) on its left and the centromere (cen) on its right. The int22h1 segment of I22 has almost complete sequence identity (i.e., >99.95% identical) to two X-chromosome segments that are located ~500 kb telomeric of F8, int22h2 and int22h3 (for clarity only one of the extragenic copies of the homologous segments, int22h2, is depicted in (a) and the upper portion of (b). The lower panel shows that intra-chromosomal homologous recombination between int22h1 and int22h3 (or int22h2) results in a cross-over structure with the corresponding element within I22, and an inversion of exons 1-22 with respect to exons 23-26 of F8. (c) Structure of the I22-inverted F8 locus. The homologous recombination between int22h1 and int22h3 (or int22h2) results in an inversion of F8 exons 1-22 with respect to exons 23-26. . This assay involves agarose-gel electrophoresis of Bcl1 digested genomic DNA isolated from subjects with HA followed by Southern blotting and hybridization with a 32 P-labeled ~990 bp probe, which represents an internal fragment of the three essentially identical F8 A genes, one residing in I22 of F8 and two located >350 kb and >430 kb telomeric of F8 that were released and purified from the commercially available plasmid, p482.6 (ATCC, catalogue no. 57203; NJ, USA), following double digestion with EcoRI and SstI. The left panel depicts analysis of samples of genomic DNA from three male individuals that were used as controls. The subject without the I22I (NOT I22I) shows three positive F8 A -containing Bcl1-bands that exist in an X-chromosome with a non-inverted F8 (~14.0 kb, ~16.0 kb & ~21.6 kb). The subject with the "distal" I22I shows the three positive F8 A -containing Bcl1-bands (~14.0 kb, ~17.6 kb & ~20.1 kb) found in an X-chromosome whose F8 is inverted due to homologous-recombination. The subject with the "proximal" I22I shows the three positive F8 A -containing Bcl1-bands (~15.5 kb, ~16.0 kb & ~20.1 kb) found in an X-chromosome whose F8 is inverted due to IHR between int22h1 and int22h2, which is closer to F8 than int22h3 and oriented similarly to int22h1. The right panel depicts analysis of genomic DNA from the individuals from whom the Inv and Nor cells examined in the present study were derived. The analysis demonstrates that the severe HA in the subject from whom the Inv cells are derived is caused by an I22I involving the "distal" homologous sequence, int22h3. As expected, the healthy male (Nor) has a wild-type non-inverted F8.
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Nor cells The sequence information with respect to infused and endogenous FVIII was used to generate a list of all possible foreign peptides that could potentially be generated proteolytically from the infused FVIII protein drug(s) upon uptake into the subject's APCs. The total number of such peptides was used in the ROC-curve analysis depicted in Fig. 4c (red curve). (C) The binding affinity of all foreign peptides identified in (B) was estimated for the MHC-II alleles carried by that subject (A3). Peptide-MHC-II complexes with K d values ≤500 nM were identified (red text) and used in the ROC-curve analysis depicted in Fig. 4c (blue curve).
